Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Molecular Weight | 552.6 g/mol |
---|---|
Molecular Formula | C26H22F2N6O4S |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 3 |
Exact Mass | 552.13913070 g/mol |
Monoisotopic Mass | 552.13913070 g/mol |
Topological Polar Surface Area | 147 A^2 |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 1030 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Talazoparib Tosylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Talazoparib Tosylate, including repackagers and relabelers. The FDA regulates Talazoparib Tosylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Talazoparib Tosylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Talazoparib Tosylate supplier is an individual or a company that provides Talazoparib Tosylate active pharmaceutical ingredient (API) or Talazoparib Tosylate finished formulations upon request. The Talazoparib Tosylate suppliers may include Talazoparib Tosylate API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Talazoparib Tosylate Drug Master File in Korea (Talazoparib Tosylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Talazoparib Tosylate. The MFDS reviews the Talazoparib Tosylate KDMF as part of the drug registration process and uses the information provided in the Talazoparib Tosylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Talazoparib Tosylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Talazoparib Tosylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Talazoparib Tosylate suppliers with KDMF on PharmaCompass.
Talazoparib Tosylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Talazoparib Tosylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Talazoparib Tosylate GMP manufacturer or Talazoparib Tosylate GMP API supplier for your needs.
A Talazoparib Tosylate CoA (Certificate of Analysis) is a formal document that attests to Talazoparib Tosylate's compliance with Talazoparib Tosylate specifications and serves as a tool for batch-level quality control.
Talazoparib Tosylate CoA mostly includes findings from lab analyses of a specific batch. For each Talazoparib Tosylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Talazoparib Tosylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Talazoparib Tosylate EP), Talazoparib Tosylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Talazoparib Tosylate USP).
LOOKING FOR A SUPPLIER?